Even though recreational cannabis will legally become available in Canada on October 17, the medical cannabis community within Canada remains strong and growing since its legal start in 2001.
As of March 2018 in Canada, there are 296,792 registrations under Health Canada’s Access to Cannabis for Medical Purposes Regulations (ACMPR), which has experienced a growth of over 120,000 since this time last year.
In the age of cannabis legalization, cannabis doctors, and Health Canada’s Licensed Producers (LPs) are poised to continue to grow and promote medical cannabis while discovering new medical and clinical applications for the plant. Strainprint will continue to be along for the journey of hundreds of thousands of cannabis patients nationwide.
Why Become a Medical Patient Before Recreational Legalization?
If you’re interested in using medical cannabis and are considering just waiting to try it once it’s fully legal and can be picked up in a store, you may be risking the route of self-medicating and falling short on the promises of medical cannabis.
Choosing to use cannabis under the supervision of a doctor will help you target your symptoms, and choose strains and methods of consumption that make a change to your medical diagnoses and their symptoms.
Accessing cannabis from a Health Canada Licenced Producer will ensure that you’re getting specific strains and products developed with medical cannabis treatment in mind. The vast array of LPs in Canada offer so many options, and there are dedicated online communities to help people navigate LPs.
Strainprint app users are able to share their experiences with the LPs and their products through the app.
How to Become a Medical Cannabis Patient
There are several ways that you can become a medical cannabis patient in the days before legalization and after. There’s no one-size fits all approach.
Here is a brief overview of the avenues you can take to access medical cannabis legally in Canada.
1) Talk to your doctor or Nurse Practitioner (in Ontario): Start the conversation about medical cannabis with your general practitioner. Discuss your reasons for interest, and what their procedures are for prescribing or recommending medical cannabis. Be aware that not all doctors are equipped to (or willing to) prescribe medical cannabis.
If your doctor is not interested in prescribing cannabis, you may opt for a cannabis-friendly clinic, which offer in-person or telemedicine appointments with educated, legal doctors who are equipped to help people retrieve their medical cannabis registration. If you use a clinic, your doctor may refer you or you may be asked to submit documentation supporting your diagnosis, and/or be assessed by the clinic’s health care team.
You can do this by requesting a copy of your medical records or having the clinic fax your doctors office on your behalf.
Some clinics have health care providers that can now diagnose anxiety and depression and other conditions without any documentation from your physician.
2. Once a doctor or Nurse Practitioner (NP) writes the prescription, it is time to choose a legal Licensed Producer (LP). We recommend choosing more than one based on your needs.
Your cannabis prescription will state a limit per day that you are allowed within your prescription. For instance, Jon Smith may be limited to consuming 1 gram per day. Some also have THC limits, depending on the doctor’s assessment. Some may also have other caveats such as using only oils.
3. Once you’ve chosen your LP (or LPs), notify your doctor of your choices and your doctor will send the prescription to the LP(s).
4. You register on the websites on the LPs that you plan to access.
5. The LPs will contact you when they have received your prescription either via email or phone call, and let you know you can place your first order! The staff at the LP and the clinics can give you guidance on what to use and limited dosing information.
6. You place your first order online or via phone! It is mailed to you, usually via Canada post or Purolator. Note: the ONLY way to access legal medical cannabis currently in Canada is through the mail.
Track Your Use with Strainprint
Strainprint is equipped with data on the products, strains, and methods of consumption offered by Canada’s LPs. Users can track their symptoms and cannabis sessions, and report the effects of their sessions as they “use cannabis better” with Strainprint. With the explore feature, users can discover the journeys of other users and talk to their cannabis doctors about the approaches they would like to try or may be right for them.
App users can also choose to authorize their physician to have access to their journaling/tracking report to help track progress and achieve optimal efficacy.
The medical cannabis community is thriving, and we will rely on the efforts of medical patients, cannabis doctors, and LPs to collect data to help us understand and cannabis to its highest potential in the medical context.
TORONTO, August 01, 2018 – Strainprint Technologies Ltd. (Strainprint™) – the leader in cannabis strain data and analytics – is excited to announce the addition of two key senior team members: Michelle Arbus, Vice President of Research & Insights, and Noah Kauffman, Director of Sales.
Michelle is a veteran of the market research industry with over a decade of experience at global research firms Ipsos and the NPD Group. While at these organizations, she conducted rigorous data analysis which provided multi-national corporations with data-driven insights and key recommendations to support their business decisions. Most recently, Michelle took her analytical expertise to the Ontario Ministry of Health (MOH) where she advised on issues such as cannabis, tobacco smoking, routine childhood immunizations and the flu. While at the Ministry of Health she led research that was instrumental for the strategic direction of health programs, initiatives or communications. Michelle will lead research efforts at Strainprint to identify key insights from Strainprint’s rich data set of 700,000 personal health records and over 10 million data-points that will lead to meaningful industry and customer reports. Michelle holds a BA Honours in Psychology from York University and an MBA from Dalhousie University.
Noah Kauffman has been helping customers purchase great software for over a decade. Utilizing a modern sales approach and a focus on customer success, Noah, has been a top producer at various technology companies like SysAid, Gubagoo, and Salesforce.com. As Director of Sales at Strainprint, Noah will be responsible for identifying market opportunities and developing inside and outbound sales processes to drive revenues. Noah holds a degree in Religious studies from the University of Waterloo.
“We are thrilled to have Noah & Michelle join our Strainprint team. These meaningful and strategic hires will help our us continue to rapidly grow as the largest longitudinal observational cannabis study in the world. Both Michelle and Noah bring unmatched skills combined with a passion for leadership and shared vision for the future of cannabis data and analytics.” Said Andrew Muroff, CEO, Strainprint Technologies Ltd.
Founded in Toronto in 2016, StrainprintTM Technologies Ltd. is the leading demand-side cannabis data and analytics company, gathering real-time cannabis consumption and efficacy data on lab-verified strains. StrainprintTM data supports global cannabis research and provides advanced business intelligence and treatment guidance to producers, retailers, medical practitioners, pharma, government and industry. Strainprint is HIPAA, PIPEDA and PHIPA privacy compliant, military-grade encrypted and all patient data is completely anonymized and at rest in Canada. Strainprint can be seamlessly embedded or integrated with most electronic medical records (EMR) and seed2sale software systems. Strainprint Analytics is accessed by customer subscription. The Strainprint App is free to patients and can be downloaded from both the iOS App Store and GooglePlay Store. www.strainprintanalytics.com. facebook, twitter, linkedin
StrainprintTM Technologies Ltd.